{
    "2018-12-13": [
        [
            {
                "time": "2023-02-13",
                "original_text": "复盘: 做好底部布局 主力重点出击17股(名单)",
                "features": {
                    "keywords": [
                        "复盘",
                        "底部布局",
                        "主力",
                        "重点出击"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-07",
                "original_text": "377亿资金争夺20股：主力资金重点出击17股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "重点出击"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-07",
                "original_text": "医药生物行业周报: 仿制药高毛时代过去, 集中度提升将催生新巨头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "集中度提升",
                        "新巨头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-07",
                "original_text": "海正药业一年两度被公开谴责：终止定增计划 再融资异常",
                "features": {
                    "keywords": [
                        "海正药业",
                        "公开谴责",
                        "终止定增",
                        "再融资异常"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}